Drug Awareness for Teenagers: Facts About Cannabis, MDMA, and Other Substances
Many teenagers encounter drugs before they have accurate information about them. This evidence-based guide covers cannabis, MDMA, and other substances teenagers commonly encounter, with honest information about risks and how families can have useful conversations.
Why Accurate Information Matters
Drug education that exaggerates risks, uses scare tactics, or presents all substances as equally and catastrophically dangerous tends to backfire with teenagers. Young people who have seen peers use cannabis without immediately dropping dead learn quickly that they were not given accurate information, and they discount future drug safety information accordingly. Honest, evidence-based information, including acknowledgement of why people use drugs, what the real risks are, and what factors make use more or less dangerous, is both more respectful and more effective.
This guide does not encourage drug use. It provides accurate information because young people who have truthful information are better positioned to make informed decisions and to stay safer if they choose to use or encounter drug use in their social environment.
Cannabis
Cannabis is the most widely used illegal drug among young people in most countries. It comes in several forms including dried herb, resin, and increasingly concentrated extracts and edibles. It is primarily smoked, but is also vaporised and eaten.
Short-term effects: Euphoria, relaxation, altered perception of time, increased appetite, reddened eyes, and in some cases anxiety, paranoia, and temporary confusion. Effects vary significantly depending on the strain, concentration, method of use, dose, and individual factors.
Risks for teenagers specifically: The developing adolescent brain is significantly more vulnerable to cannabis harms than the adult brain. Regular cannabis use during adolescence is associated with:
- Increased risk of psychosis and schizophrenia, particularly in those with a genetic predisposition or family history
- Negative effects on memory, attention, and learning that may be persistent
- Higher rates of cannabis use disorder (dependence) compared to adults who start using later
- Worsening of anxiety and depression in those already vulnerable
The strength problem: Cannabis available today is generally significantly more potent than cannabis available a generation ago, with much higher concentrations of THC (the psychoactive compound). Higher-strength cannabis carries greater mental health risks, particularly for young people.
Honest risk calibration: Not everyone who uses cannabis occasionally suffers harm. But regular use during adolescence does carry meaningful risks, particularly for mental health, and the risks are not evenly distributed: some young people are significantly more susceptible than others, and it is not always possible to know who falls into that category in advance.
MDMA (Ecstasy)
MDMA, commonly known as ecstasy or molly, is a stimulant and mild psychedelic that produces feelings of emotional closeness, euphoria, and heightened sensory experience. It is associated with club, festival, and party environments.
Short-term risks: Overheating (hyperthermia) is the most significant acute risk, particularly in hot environments with physical activity. MDMA impairs the body's ability to regulate temperature, and deaths associated with MDMA are most commonly related to this. Drinking too much water can also be dangerous, as MDMA causes the body to retain water, and hyponatraemia (dangerously low blood sodium from overhydration) has caused deaths. Adulterants in tablets sold as MDMA are a significant risk: many tablets contain other substances, including PMA and PMMA which are significantly more toxic than MDMA.
Mental health effects: MDMA depletes serotonin, producing a low mood period (sometimes called a comedown) in the days after use. Regular use exacerbates this depletion and is associated with depression, anxiety, and cognitive difficulties.
The adulterant problem: Because MDMA is illegal and unregulated, there is no quality control on what is sold as ecstasy. Fentanyl and other synthetic opioids have been found in tablets sold as MDMA in some markets. Drug checking services (where legal) and reagent test kits are available as harm reduction tools, but do not provide full safety.
Cocaine and Crack Cocaine
Cocaine is a stimulant derived from the coca plant that produces intense but short-lived euphoria and increased energy. It is typically snorted as a powder or smoked as crack cocaine.
Risks: Cardiovascular risks including heart attack and stroke are the primary physical harms, even in healthy young people. Cocaine is highly addictive. Regular use causes significant mental health consequences including anxiety, paranoia, and depression. The comedown from cocaine is unpleasant, which drives repeat use. Like MDMA, cocaine purchased illegally is commonly adulterated, including with levamisole (an anti-parasitic drug with significant health consequences) and synthetic opioids.
Ketamine
Ketamine is a dissociative anaesthetic used medically that is also used recreationally. It produces feelings of dissociation, distorted perception, and in higher doses, an intense dissociative state sometimes called a k-hole.
Risks: Bladder damage from regular ketamine use is severe and can be permanent, requiring surgical intervention or even removal of the bladder. This risk is not widely known among young users. Ketamine is also dangerous in combination with depressants including alcohol. Psychological dependence develops readily in regular users.
Nitrous Oxide
Nitrous oxide (laughing gas) is a colourless gas used medically as an anaesthetic and recreationally for its brief euphoric effect. It is inhaled from balloons or whipped cream chargers.
Risks: The primary serious risk is vitamin B12 depletion with regular use, which causes potentially permanent neurological damage. Falls and accidents due to sudden loss of consciousness are an acute risk. Nitrous oxide is classified as a controlled substance in an increasing number of countries following health concerns about recreational use.
Talking to Teenagers About Drugs
The same principles that apply to alcohol conversations apply here: ongoing honest dialogue is more effective than one-time lectures. Acknowledging that many people use drugs without instantly catastrophic consequences, while being clear about the genuine risks (particularly those specific to the developing adolescent brain), treats teenagers as intelligent people capable of engaging with real information.
Ensuring teenagers know they can call a trusted adult if they or a friend are in difficulty without fear of punishment, regardless of the circumstances, is a potentially lifesaving conversation to have in advance.
Conclusion
Drug education works best when it is honest, evidence-based, and treats young people with enough respect to give them real information rather than scare tactics. Understanding what different substances do, what the specific risks are, and why those risks are elevated for teenagers provides a basis for genuine informed decision-making that vague warnings do not.